Beam Therapeutics
Developing precision genetic medicines
- B2B
About Beam Therapeutics
Pioneering CRISPR base editing technology to develop precision genetic medicines for life-long cures, while fostering a community of fearless innovators
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2017
- Revenue
- $140MFY2025, publicly reported
- Website
- beamtx.com
- linkedin.com/company/beamtx
Beam Therapeutics at a glance
Beam Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in cambridge, massachusetts, United States.
Beam Therapeutics was founded in 2017.
Beam Therapeutics has 251–1,000 employees.
Beam Therapeutics's revenue is $140M (FY2025, publicly reported).
Selling to companies like Beam Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies